Earnings History Data for AIM ImmunoTech (AIM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
AIM ImmunoTech
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | AIM | Hemispherx BioPharma, Inc. | 13.71 | -0.06 | -0.10 | -0.16 | AIM ImmunoTech GAAP EPS of -$0.06 [11/15/2024 6:39 AM] |
0.2279 | -0.02 (-9.81%) |
0.27 | 0.02 (8.79%) |
0.21 - 0.62 | 706,638 | 240,000 | 98,157 | ||
| 16-05-2024 | PM | AIM | Hemispherx BioPharma, Inc. | 19.18 | -0.12 | 0.00 | -0.08 | AIM ImmunoTech GAAP EPS of -$0.12 [5/16/2024 7:33 AM] |
0.3952 | 0.0 (-1.10%) |
0.40 | 0.0 (0.35%) |
0.32 - 0.75 | 267,203 | 190,000 | 13,649 | ||
| 14-11-2023 | PM | AIM | Hemispherx BioPharma, Inc. | 20.59 | -0.16 | 0.00 | -0.13 | AIM ImmunoTech GAAP EPS of -$0.16 misses by $0.04 [11/15/2023 7:37 AM] |
0.4748 | 0.02 (4.58%) |
0.48 | 0.03 (5.73%) |
0.29 - 0.84 | 75,474 | 200,000 | 644 | ||
| 15-08-2023 | PM | AIM | Hemispherx BioPharma, Inc. | 28.25 | -0.10 | 0.00 | -0.10 | AIM ImmunoTech GAAP EPS of -$0.10 beats by $0.01, revenue of $0.04M beats by $0.02M [8/15/2023 6:10 AM] |
0.6473 | -0.04 (-5.64%) |
0.69 | 0.0 (0.00%) |
0.29 - 0.84 | 162,863 | 110,000 | 2,692 | ||
| 12-05-2023 | PM | Before the open (May 16) |
AIM | Hemispherx BioPharma, Inc. | 17.48 | -0.08 | 0.00 | -0.08 | AIM ImmunoTech GAAP EPS of -$0.08 [5/15/2023 9:28 AM] |
0.4240 | 0.0 (-0.24%) |
0.44 | 0.02 (3.72%) |
0.29 - 1.05 | 96,163 | 60,000 | 664 | |
| 31-03-2022 | AH | 5:15 PM ET (Mar 31) |
AIM | Hemispherx BioPharma, Inc. | 42.87 | -0.12 | 0.00 | -0.09 | AIM ImmunoTech GAAP EPS of -$0.04 [3/31/2022 4:43 PM] |
1.06 | 0.01 (0.47%) |
1.05 | -0.01 (-0.94%) |
0.55 - 2.51 | 131,442 | 240,000 | 2,101 | |
|
||||||||||||||||||
| 18-05-2021 | PM | AIM | Hemispherx BioPharma, Inc. | 79.78 | -0.08 | 0.00 | -0.22 | AIM ImmunoTech EPS in-line, misses on revenue [5/18/2021 7:41 AM] |
2.08 | 0.0 (0.00%) |
2.04 | -0.04 (-1.92%) |
1.60 - 4.30 | 264,971 | 800,000 | 7,771 | ||
| 31-03-2021 | PM | AIM | Hemispherx BioPharma, Inc. | 84.94 | -0.09 | 0.00 | 0.00 | AIM ImmunoTech EPS misses by $0.02, misses on revenue [3/31/2021 10:39 AM] |
0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | ||
|
|
||||||||||||||||||